Connection
Thomas Anchordoquy to Doxorubicin
This is a "connection" page, showing publications Thomas Anchordoquy has written about Doxorubicin.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.023 |
|
|
|
-
Tilden SG, Ricco MH, Hemann EA, Anchordoquy TJ. Exploiting a type III interferon response to improve chemotherapeutic safety and efficacy. Eur J Pharm Sci. 2025 Jan 01; 204:106974.
Score: 0.820
-
Smyth T, Kullberg M, Malik N, Smith-Jones P, Graner MW, Anchordoquy TJ. Biodistribution and delivery efficiency of unmodified tumor-derived exosomes. J Control Release. 2015 Feb 10; 199:145-55.
Score: 0.103
-
Verhoef JJ, Carpenter JF, Anchordoquy TJ, Schellekens H. Potential induction of anti-PEG antibodies and complement activation toward PEGylated therapeutics. Drug Discov Today. 2014 Dec; 19(12):1945-52.
Score: 0.101